
143.58MEUR
Type
Common Stock
Exchange
PA
Currency Code
EUR
Currency Name
Euro
Country Name
France
Country ISO
FR
ISIN
FR0012596468
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.15
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.1
Wall Street Target Price
1.14
EPS Estimate Current Year
-0.02
EPS Estimate Next Year
-0.05
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
5,814,000
Gross Profit TTM
5,814,000
EBITDA
-29,789,000
Profit Margin
0.00%
Return On Assets TTM
-26.12%
Return On Equity TTM
-50.47%
Revenue Per Share TTM
0.019
Qtly Revenue Growth YOY
5.00%
Diluted Eps TTM
-0.1
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
21.4058
Price Book MRQ
2.8965
Enterprise Value Revenue
1304
Enterprise Value EBITDA
-7
12.00
2.04%2.86
1.38%2.10
1.26%21.60
0.93%1.56
0.78%0.86
0.12%1.15
-14.74%90.45
-3.62%3.31
-3.49%30.04
-0.40%Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.
Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.
Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.